Merck (MRK) Change in Inventory (2009)
Merck's (MRK) quarterly Change in Inventory came in at -$1.1 billion in Q4 2009, down 831.08% quarter-over-quarter from $148.0 million in Q3 2009.
Powered by 
Analysis
Merck (MRK) Change in Inventory (2009) Analysis & Trends
Merck (MRK) has reported Change in Inventory for 1 consecutive years, with -$1.1 billion the latest figure, recorded in Q4 2009.
- On a quarterly basis, Change in Inventory changed N/A year-over-year to -$1.1 billion in Q4 2009; TTM through Dec 2009 was -$370.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 41.32% from the prior year.
- Change in Inventory was -$1.1 billion for Q4 2009 at Merck, down from $148.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $148.0 million in Q3 2009 and troughed at -$1.1 billion in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 11.88 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 17.70 Mn |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | 6.50 Mn |